You are here

Medtech firm Biolidics' shares slump in Catalist debut


SHARES of medical technology company Biolidics slumped on their trading debut on the Catalist board, with the stock closing down 16 per cent from its listing price of S$0.28.

The stock opened at S$0.265 on Wednesday morning, and drifted lower through the trading day. It...

Market voices on: